KIAA1033 inhibitors encompass a chemical class aimed at modulating the activity of KIAA1033, which is a key component in the regulation of actin filament assembly and endosomal trafficking. These inhibitors target various molecular processes and signaling pathways that underpin KIAA1033's cellular functions. By disrupting the dynamic equilibrium of actin polymerization and depolymerization, the inhibitors can significantly impact the cytoskeletal framework. Actin dynamics are crucial for numerous cellular activities, including maintaining cell morphology, promoting cell movement, and orchestrating cytokinesis. KIAA1033 is integral to these processes as it contributes to the controlled polymerization of actin through its association with the WASH complex.
The scope of KIAA1033 inhibitors also encompasses the modulation of vesicle trafficking, an essential cellular mechanism that governs the movement of proteins and lipids across various cellular compartments and the plasma membrane. Inhibitors that interfere with this pathway can change how the WASH complex, which includes KIAA1033, is recruited and assembled on the membranes of endosomes, affecting the sorting and delivery of endosomal contents. Such interference can lead to modifications in the endocytic and exocytic pathways, with downstream effects on the distribution and functioning of cellular constituents. Additionally, the activity of KIAA1033 inhibitors can induce changes in the structure of the Golgi apparatus, a central organelle in protein modification and sorting. Altering the Golgi apparatus's function can have extensive consequences on cellular homeostasis and organization. The molecules classified as KIAA1033 inhibitors are varied, each affecting the cell in distinct ways. Their collective ability to influence the cellular roles associated with KIAA1033 highlights the sophisticated interdependency between the cytoskeleton, membrane trafficking, and cell signaling cascades.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Disrupts actin polymerization by binding to G-actin, which could possibly inhibit KIAA1033 by impeding the actin remodeling it is involved in. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Interferes with actin polymerization by capping the fast-growing ends of actin filaments, which could possibly inhibit KIAA1033 by impacting the actin-dependent processes it regulates. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Stabilizes actin filaments, which could possibly inhibit KIAA1033 by preventing the dynamic rearrangement of the actin cytoskeleton necessary for its role in endosomal trafficking. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $315.00 $1020.00 | 5 | |
Inhibits the Arp2/3 complex responsible for actin nucleation, which could possibly inhibit KIAA1033's ability to promote actin nucleation through the WASH complex. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $48.00 $122.00 $432.00 $812.00 | 4 | |
Inhibits N-WASP, upstream of Arp2/3 complex activation. By inhibiting N-WASP, which could possibly inhibit KIAA1033's function as part of the complex activating Arp2/3. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Inhibits dynamin, which could possibly inhibit KIAA1033 by altering endosomal trafficking and the actin-dependent processes it is involved in. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts the Golgi apparatus, which could possibly inhibit KIAA1033 by influencing endosomal trafficking and its associated activities. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Affects endosomal pH and trafficking, which could possibly inhibit KIAA1033 by disrupting the sorting of cargo in endosomes it is implicated in. | ||||||
4-Amino-N-(1,1-dimethylethyl)-4,5-dihydro-3-(1-methylethyl)-5-oxo-1H-1,2,4-triazole-1-carboxamide | 129909-90-6 | sc-479746 | 100 mg | $380.00 | ||
Inhibits clathrin-mediated endocytosis, which could possibly inhibit KIAA1033 by modifying endosomal trafficking and altering the functions related to it. | ||||||